Platform
Workflows
Antibody Discovery
Viral Neutralization
Cell Line Development
Cell Therapy Development
Synthetic Biology
Advanced Automation
Beacon
®
Optofluidic System
Beacon Select™ Optofluidic System
The Lightning
®
Optofluidic System
Culture Station™ System
Technology
Company
TechAccess Subscriptions
Innovation Centers
News & Articles
Press Releases
Events
Company
Investor Relations
Careers
Customer Spotlights
Publications
Careers
Resources
Support
Get In Touch
Latest
News
News
07.13.22
ARTICLE: Broadly neutralizing antibodies target the coronavirus fusion peptide
News
04.10.22
The Pandemic Is Driving Innovative Microfluidic Disease Detection
News
08.11.21
Berkeley Lights and Bayer Announce Agreement to Spur Discovery of Next-Generation Traits
News
08.05.21
Mapping the Future of Cell Culture and Cell Line Development
News
05.25.21
Meet The Collaboration Solving Some Of Antibody Discovery’s Toughest Problems
News
05.11.21
Leveraging optofluidics to make therapeutic antibody discovery easier
News
04.15.21
Researchers pivot from COVID-19 response to preventing future pandemics
News
04.12.21
Military programs aiming to end pandemics forever
News
03.05.21
From Discovery To Delivery: Addressing Challenges in Cell Therapy
News
03.04.21
Biotech’s Brave New World: Bay Area startups band together to ramp up coronavirus research and testing
News
01.13.21
JP Morgan Healthcare Conference 2021, Day Two:Qiagen, Invitae, Agilent, Sema4, More
News
11.05.20
Finding the Best Cell for the Job
News
11.01.20
Pinpointing Bioprocess Development Success
News
10.21.20
Big Tech Is Under Pressure. Here’s Where to Find Growth
News
10.05.20
Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells
News
10.01.20
Soaring Biomedical IPOs Raise Questions About Money Left on the Table
News
09.22.20
Berkeley Lights Will Receive IPO of the Year Award at SynBioBeta 2020
News
09.14.20
Optofluidics Technology Accelerates Discovery of COVID-19 Treatments
1
2
›
»